Evidence map›Paper›PMID 37532949›Full record

ArticleHypertension research : official journal of the Japanese Society of Hypertension2023

Cross-sectional survey of hypertension management in clinical practice in Japan: the Kanagawa Hypertension Study 2021 conducted in collaboration with Japan Medical Association Database of Clinical Medicine.

Kazuo Kobayashi, Keiichi Chin, Nobuo Hatori, Takayuki Furuki, Hiroyuki Sakai, Masaaki Miyakawa, Kei Asayama, Narumi Eguchi, Tomohiro Katsuya, Kouichi Tamura and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Hypertension research : official journal of the Japanese Society of Hypertension, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Association of hypertension specialist treatment with blood pressure control in Japanese primary care: The J-DOME study.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Article
  4. Observational
  5. Blood pressure status, JSH 2019-based control rate, and associated factors among community-dwelling adults: The NOSE study.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Article
  6. Article
  7. Article
  8. Regional disparities in blood pressure control after hypertension treatment initiation in Japan: a real-world data analysis.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Article
  9. The Japanese Society of Hypertension Guidelines for the management of elevated blood pressure and hypertension 2025 (JSH2025).Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Comparison between sacubitril/valsartan and thiazide diuretics among patients with uncontrolled hypertension in Japan.Hypertension research : official journal of the Japanese Society of Hypertension · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Kazuo KobayashiCommittee of Hypertension and Kidney Disease, Kanagawa Physicians Association, Yokohama, Japan. k-taishi@xc4.so-net.ne.jp.
Keiichi ChinCommittee of Hypertension and Kidney Disease, Kanagawa Physicians Association, Yokohama, Japan.
Nobuo HatoriKobayashi Hospital, Odawara, Japan.
Takayuki FurukiCommittee of Hypertension and Kidney Disease, Kanagawa Physicians Association, Yokohama, Japan.
Hiroyuki SakaiCommittee of Hypertension and Kidney Disease, Kanagawa Physicians Association, Yokohama, Japan.
Masaaki MiyakawaJapan Medical Association, Tokyo, Japan.
Kei AsayamaDepartment of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan.
Narumi EguchiJapan Medical Association Research Institute, Tokyo, Japan.
Tomohiro KatsuyaKatsuya Clinic, Hyogo, Japan.
Kouichi TamuraDepartment of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.
Kazuyoshi SatoCommittee of Hypertension and Kidney Disease, Kanagawa Physicians Association, Yokohama, Japan.
Akira KanamoriCommittee of Hypertension and Kidney Disease, Kanagawa Physicians Association, Yokohama, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We aim to assess the data of patients with hypertension in Kanagawa Prefecture, Japan, collected in 2021 that were provided by the Japan Medical Association Database of Clinical Medicine. Data collected in 2011 and 2014 by the Kanagawa Physicians Association were used for comparative analysis. The target blood pressure (BP) achievement rates for patients whose target office and home BP were <140/90 mmHg and <135/85 mmHg, respectively, were 72.5% and 75.8% in 2011, 66.0% and 68.5% in 2014, and 46.7% and 83.3% in 2021, respectively. The target office BP achievement rate in 2021 was significantly lower than those in 2011 and 2014 (p ≤ 0.009). In contrast, there was no significant difference and improvement of the achievement rates for patients whose target office and home BP were <130/80 mmHg and <125/75 mmHg, respectively, among the three surveys. After the Japanese Society of Hypertension 2019 Guidelines were released, the achievement rates for patients whose target BP was tightened were significantly lower than those for patients with unchanged target BP (office/home, p < 0.001/0.04). The proportion of the patients who achieved their office and home target BP using more than three drugs was 38.5% and 20.0%, respectively. In the present analysis, we unveiled the current problems encountered in the clinical management of hypertension in Japan. In particular, efforts should be focused on the management of patients that require strict BP control.

Indexed as

Clinical MedicineHypertensionAntihypertensive AgentsBlood PressureCross-Sectional StudiesHumansJapanAntihypertensive AgentsAchievement rateHypertension paradoxJSH guidelinesTarget blood pressure

Identifiers

PMID37532949

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.